Abstract
In order to improve bone regeneration, the use of mesenchymal stem cells (MSC) from different sources have been widely explored. MSCs from adipose tissue (MSC-AT) are an attractive alternative since a higher number of cells are easily harvested at lesser morbidity compared to cells obtained from other sources. However, their use is limited due to their lower less osteogenic potential. To …